Navigation Links
Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
Date:2/15/2013

San Diego, CA (PRWEB) February 15, 2013

Nasseo, Inc., a medical device company based in San Diego, CA, is pleased to announce that it has closed its $520K seed financing round. BioInspire™, a medical technology incubator that funded Nasseo earlier this year, leads the round along with an internationally renowned dentist. The Nasseo TiArray™ dental implant system, the first product based on Nasseo’s proprietary implant surface modification technology, has been developed for diabetics and smokers with poor bone healing who are seeking dental implants but have limited treatment options with today’s technology. Nasseo offers dentists cost-effective, high quality, and easy-to-use implants that significantly improve clinician productivity and expand patient care options.

BioInspire™ is a collaborative partnership between BioAccel®, Plaza Companies, and the City of Peoria, Arizona, that provides working capital and space to those companies selected and admitted per its application criteria. BioInspire™ focuses on directly addressing the challenges of commercializing medical devices by providing portfolio companies with assistance in funding, partnerships and mentorship.

Dr. Garrett Cale Smith, Co-Founder and CEO of Nasseo, says, “We are honored to be selected as a BioInspire™ portfolio company and to be identified as a medtech company that is poised for investment based upon the unmet clinical need that our enabling technology is addressing.”

Nasseo’s technology has received increasingly enthusiastic reception from members across diverse sectors of the scientific and investment community. Most recently, Nasseo participated in World’s Best Technology (WBT) Innovation Marketplace 2012, the premier showcase for life science and technology innovation. There, Nasseo was selected as part of an elite group to present its surface modification technology to venture capitalists and other attendees at the event, which is sponsored by Northrup Grumman. Kayvon Pourmirzaie, JD, Nasseo’s Co-Founder and COO, confirms, “Our inclusion in BioInspire™ is a significant milestone as it gives us access to a wealth of resources and opportunities that will support moving forward aggressively with our go-to-market strategy.”

Nasseo is joining the BioInspire™ community at the same time as it experiences internal growth with the addition of Mr. Brian Jaffe to its Board of Advisors. Mr. Jaffe has over 15 years of senior level experience in dental implants and medical devices and is currently the president of Quantive LLC, a consulting firm specializing in helping dental and medical device companies launch new products in the United States. He was previously Vice President of Sales and Marketing at Implant Direct, a leading global manufacturer of dental implants and prosthetics that was acquired by Danaher Corporation for $300M in 2010. He holds an MBA from Harvard Business School and a Masters in Science Degree in Mechanical Engineering from UC Berkeley.

Dr. Smith says, “We are joining BioInspire™ and bringing Brian in at an exciting time in Nasseo’s growth. We will continue to seek out every opportunity, internally and externally, to successfully commercialize our first product, the TiArray™ dental implant system, to reach a large and underserved group of patients.”

The company plans to raise a $3M+ Series A investment round in mid 2013 to catalyze production and sales.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in San Diego, CA. For more information, please visit our website at http://www.nasseo.com or contact us at info(at)nasseo.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10436080.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
2. Michael Berman Joins InspireMD Board
3. Rudy Mazzocchi Joins the Greatbatch Board of Directors as he Continues to Expand his Presence in the Med-tech Industry
4. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
5. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. John A. Orwin Joins Array BioPharma Board Of Directors
8. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
9. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
10. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
11. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):